ono-ae1-329 and Parkinsonian-Disorders

ono-ae1-329 has been researched along with Parkinsonian-Disorders* in 1 studies

Other Studies

1 other study(ies) available for ono-ae1-329 and Parkinsonian-Disorders

Article	Year
Anti-Inflammatory and Neuroprotective Effects of PGE Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2017, Volume: 12, Issue:2 Inflammation is a ubiquitous factor accompanying normal aging and neurodegeneration, and recent studies indicate a major contribution of inducible cyclooxygenase (COX-2) and its downstream prostaglandin signaling pathways in modulating neuroinflammatory responses and neuronal function. We have previously shown that the prostaglandin PGE Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Dinoprostone; Male; Methyl Ethers; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; Neuroprotective Agents; Parkinsonian Disorders; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction	2017

Article

Year

Anti-Inflammatory and Neuroprotective Effects of PGE

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2017, Volume: 12, Issue:2

Inflammation is a ubiquitous factor accompanying normal aging and neurodegeneration, and recent studies indicate a major contribution of inducible cyclooxygenase (COX-2) and its downstream prostaglandin signaling pathways in modulating neuroinflammatory responses and neuronal function. We have previously shown that the prostaglandin PGE

Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Dinoprostone; Male; Methyl Ethers; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; Neuroprotective Agents; Parkinsonian Disorders; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction

2017